WuXi AppTec Co., Ltd. (HKG:2359)
108.60
+0.10 (0.09%)
Oct 31, 2025, 4:08 PM HKT
WuXi AppTec Revenue
WuXi AppTec had revenue of 12.06B CNY in the quarter ending September 30, 2025, with 15.26% growth. This brings the company's revenue in the last twelve months to 43.07B, up 16.92% year-over-year. In the year 2024, WuXi AppTec had annual revenue of 37.92B, down -1.97%.
Revenue (ttm)
43.07B CNY
Revenue Growth
+16.92%
P/S Ratio
6.84
Revenue / Employee
1.09M CNY
Employees
39,414
Market Cap
321.78B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 37.92B | -760.22M | -1.97% |
| Dec 31, 2023 | 38.68B | -676.78M | -1.72% |
| Dec 31, 2022 | 39.35B | 16.45B | 71.84% |
| Dec 31, 2021 | 22.90B | 6.37B | 38.50% |
| Dec 31, 2020 | 16.54B | 3.66B | 28.46% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JD Health International | 71.34B |
| BeOne Medicines AG | 35.81B |
| Sino Biopharmaceutical | 33.49B |
| Alibaba Health Information Technology | 32.81B |
| CSPC Pharmaceutical Group | 28.49B |
| WuXi Biologics | 21.98B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| Innovent Biologics | 12.52B |